bioRxivMicrobiologyPreprint
In vitro analysis of Fusobacterium Polymorphum from oral leukoplakia patients identifies 'high-risk' isolates
Abstract
IntroductionMounting evidence links F. nucleatum, particularly subsp. polymorphum (now classified as F. polymorphum) to oral squamous cell carcinoma (OSCC). However, not all studies support this association, and its ubiquitous presence in health complicates its role as a driver of disease, raising a fundamental question: Can some isolates be pathogenic "high risk" while others are not? Here, we investigated the carcinogenic potential of clinical isolates of F. polymorphum from oral dysplastic lesions. MethodsSixteen, fully sequenced F. polymorphum isolates from healthy subjects (6 isolates) or patients with mild epithelial dysplasia (3 isolates), moderate dysplasia (3 isolates) or severe dysplasia/OSCC (4 isolates) were included. The isolates were assessed for their effect on the proliferation, migration, invasion, transcriptome and cytokinome of dysplastic oral keratinocytes (DOK). The isolates were also subject to RNA-seq and secreted amyloid FadA analyses. ResultsAlthough genetically indistinguishable, the isolates differed markedly in their effects on dysplastic oral keratinocytes (DOK) with isolates from dysplastic lesions demonstrating enhanced proliferation, migration, and invasion of DOK in proportion to the dysplasia severity of their clinical origin. Strikingly, amyloid-like FadA levels were also significantly higher in dysplasia-associated "high-risk" isolates and correlated with their pro-carcinogenic effects. RNA-seq further showed upregulation of heme acquisition genes in high risk isolates. Transcriptome and cytokine profiling of DOK revealed a uniform pro-inflammatory response across all isolates, independent of origin, but genes and pathways related to proliferation correlated with dysplasia severity. Supporting this, 45% of the most severity-correlated host genes identified in vitro were also differentially expressed in the same direction in tumors versus normal tissues in the TCGA OSCC dataset. ConclusionThese results show, for the first time, that clinical oral isolates of F. polymorphum vary in their carcinogenic properties, establishing the novel concept of "high-risk" versus "low-risk" isolates in oral carcinogenesis, potentially driven by genome-independent regulation.
- organism: human
- assay: bulk RNA-seq
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Characterization of Clinical Fusobacterium nucleatum Isolates from Oral Squamous Cell Carcinoma Patients
Serene Liqing Lim, Wan-Hsin Hsueh, … I‐Hsiu Huang·bioRxiv·Jan 8, 2025
- The prevalence of Fusobacterium nucleatum subspecies in the oral cavity stratifies by local health status
M. Krieger, Y. M. AbdelRahman, … J. Merritt·bioRxiv·Oct 25, 2023
- Fusobacterium nucleatum present in the saliva of oral cancer subjects can activate niche defense of oral squamous cell carcinoma
P. J. Saikia, L. Pathak, … B. Das·bioRxiv·Oct 10, 2023
- Fusobacterium nucleatum is enriched in invasive biofilms in colorectal cancer
Jessica Queen, Zam Cing, … Cynthia L. Sears·npj Biofilms and MicrobiomesPeer-reviewed·May 20, 2025
- Total RNA sequencing reveals gene expression and microbial alterations shared by oral pre-malignant lesions and cancer.
Mohammed Muzamil Khan, Jennifer L. Frustino, … Stefano Monti·Human GenomicsPeer-reviewed·Aug 4, 2023
- Fusobacterium nucleatum outer membrane vesicles activate the TNFR1/NF-κB signaling pathway to promote OSCC proliferation
Zhengrui Li, Jian Liu, … Ling Zhang·bioRxiv·Oct 31, 2025